Reference number : 236-2018-2019-Q3-00878, amendment number : 1, agreement type : G, recipient legal name : Korneluk, Robert G, recipient country : CA, recipient province : ON, recipient city : Ottawa, recipient postal code : K1H 8L1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : 144903.0, agreement value : 339709.0, agreement start date : 2018-10-01, agreement end date : 2019-06-30, description english : Combined IAP antagonism and immunotherapy for cancer treatment, description french : Combined IAP antagonism and immunotherapy for cancer treatment, expected results english : nan, expected results french : nan, additional information english : Amendment 1: Agreement Value in CAD and Projected Agreement End Date., additional information french : Modification 1: Valeur de l'entente en dollars canadiens et la date de fin prévue de l'entente., owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada